Evidence map›Paper›PMID 30544749›Full record

ReviewGenes2018

Mechanisms of DNA Methyltransferase Recruitment in Mammals.

Marthe Laisné, Nikhil Gupta, Olivier Kirsh, Sriharsa Pradhan, Pierre-Antoine Defossez

Open access · goldAbstract readReview
In one paragraph

Review in Genes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Marthe LaisnéEpigenetics and Cell Fate, UMR7216 CNRS, University Paris Diderot, Sorbonne Paris Cité, 75013 Paris, France. marthe.laisne@gmail.com.
Nikhil GuptaEpigenetics and Cell Fate, UMR7216 CNRS, University Paris Diderot, Sorbonne Paris Cité, 75013 Paris, France. nikhilsspp@gmail.com.ORCID 0000-0002-5605-0459
Olivier KirshEpigenetics and Cell Fate, UMR7216 CNRS, University Paris Diderot, Sorbonne Paris Cité, 75013 Paris, France. olivier.kirsh@univ-paris-diderot.fr.ORCID 0000-0001-6200-5681
Sriharsa PradhanNew England Biolabs, 240 County Rd, Ipswich, MA 01938, USA. pradhan@neb.com.
Pierre-Antoine DefossezEpigenetics and Cell Fate, UMR7216 CNRS, University Paris Diderot, Sorbonne Paris Cité, 75013 Paris, France. pierre-antoine.defossez@univ-paris-diderot.fr.
Centre National de la Recherche Scientifique · FRNew England Biolabs (United States) · US

Funding

Agence Nationale de la Recherche ANR-11-IDEX-0005-01/ANR-11-LABX-0071Agence Nationale de la Recherche ANR-15-CE12-0012-0Institut National Du Cancer 2015-1-PLBio-01-DRA-1
6 · The paper itself

Abstract

DNA methylation is an essential epigenetic mark in mammals. The proper distribution of this mark depends on accurate deposition and maintenance mechanisms, and underpins its functional role. This, in turn, depends on the precise recruitment and activation of de novo and maintenance DNA methyltransferases (DNMTs). In this review, we discuss mechanisms of recruitment of DNMTs by transcription factors and chromatin modifiers-and by RNA-and place these mechanisms in the context of biologically meaningful epigenetic events. We present hypotheses and speculations for future research, and underline the fundamental and practical benefits of better understanding the mechanisms that govern the recruitment of DNMTs.

Indexed as

DNA methylationDNA methyltransferasesepigenetics

Identifiers

PMID30544749
PMCPMC6316769
OpenAlexW2905341870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.